martes, 31 de diciembre de 2019

Endo Pharmacauticals has discontinued Collagenase Clostridium Histolyticum (CCH) injection by andromedical

Endo Pharmacauticals has discontinued Collagenase Clostridium Histolyticum (CCH) injection by andromedical: Endo Pharmacauticals has
discontinued Collagenase Clostridium Histolyticum (CCH) injection in Australia
and Asia, and plans to do the same to whole Europe by the end of 2019. The American labor...

No hay comentarios: